Gemesis is proud to announce a new strategic partnership with ProteoY, an innovative biotechnology company developing rapid yeast-based production platforms for proteins, peptides, and RNA.
This collaboration reflects Gemesis's commitment to supporting cutting-edge industrial and scientific technologies through advanced automation and engineering solutions.
By combining ProteoY's expertise in biological production systems with Gemesis’ know-how in robotics, automated machinery, and complex process control, the partnership aims to accelerate the development of next-generation bioproduction tools.
As part of this collaboration, Gemesis is currently developing an initial automated platform dedicated to the creation and monitoring of biological production clones. This system is designed to improve process efficiency, traceability, reproducibility, and workflow management while reducing manual intervention.
The project represents an important first step toward a broader objective: the automation of larger segments of the bioproduction process..
In the future, the technologies envisioned by both companies could enable laboratories, research centers, and industrial organizations to deploy compact and highly automated systems capable of supporting local biomolecule production.
For Gemesis, this partnership also highlights the growing role of automation and robotics in the biotechnology sector, where flexibility, precision, and scalability are becoming increasingly critical.